An analysis of the genetic activity of brain cells in individuals who have died with Alzheimer's disease has revealed the ...

Alzheimer’s disease may harm the brain in two distinct phases, according to a new study funded by the National Institutes of ...

Nektar Therapeutics said that a phase 1 study examining a combination of NKTR-255 in combination with an autologous ...

The FDA has implemented a partial hold on a phase 3 non-small cell lung cancer trial run by BioNTech and OncoC4 after seeing ...

Alzheimer’s disease might damage the brain in two distinct phases, a new study suggests.An early phase that occurs s ...

Alzheimer’s Disease May Damage the Brain in Two Phases - NIH Study Uncovers Which Cell Types May Be Harmed First ...

Capricor Therapeutics is taking a victory lap for their phase 2 Duchenne muscular dystrophy (DMD) trial. | Capricor ...

New details have emerged into how Alzheimer’s disease affects the brain. Researchers have identified cellular changes in the ...

The ICMR has formalized a Memorandum of Agreement (MoA) with Zydus for a Phase IIa double-blind, randomized, ...

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative ...

Alzheimer's disease might damage the brain in two distinct phases, a new study suggests. An early phase that occurs slowly ...